These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 18653736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.
    Rito Y, Flores J, Fernández-Aguilar A, Escalante-Membrillo C, Barboza MA, Amezcua L, Corona T.
    Acta Neurol Belg; 2018 Mar; 118(1):47-52. PubMed ID: 28975580
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E, Orsini M, Daures JP, Camu W.
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.
    Laursen JH, Søndergaard HB, Sørensen PS, Sellebjerg F, Oturai AB.
    Mult Scler Relat Disord; 2016 Nov; 10():169-173. PubMed ID: 27919484
    [Abstract] [Full Text] [Related]

  • 6. Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis.
    Lin R, Taylor BV, Simpson S, Charlesworth J, Ponsonby AL, Pittas F, Dwyer T, van der Mei IA.
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):399-404. PubMed ID: 23868949
    [Abstract] [Full Text] [Related]

  • 7. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
    Fitzgerald KC, Munger KL, Köchert K, Arnason BG, Comi G, Cook S, Goodin DS, Filippi M, Hartung HP, Jeffery DR, O'Connor P, Suarez G, Sandbrink R, Kappos L, Pohl C, Ascherio A.
    JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.
    Weinstock-Guttman B, Zivadinov R, Qu J, Cookfair D, Duan X, Bang E, Bergsland N, Hussein S, Cherneva M, Willis L, Heininen-Brown M, Ramanathan M.
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):189-95. PubMed ID: 21047880
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.
    Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A.
    Mult Scler; 2005 Jun; 11(3):266-71. PubMed ID: 15957505
    [Abstract] [Full Text] [Related]

  • 13. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
    Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I.
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China.
    Zhang Y, Liu G, Han X, Dong H, Geng J.
    J Neuroimmunol; 2016 Aug 15; 297():127-31. PubMed ID: 27397085
    [Abstract] [Full Text] [Related]

  • 18. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis.
    Wang C, Zeng Z, Wang B, Guo S.
    J Nutr Health Aging; 2018 Aug 15; 22(1):38-43. PubMed ID: 29300420
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.
    Smolders J, Menheere P, Thewissen M, Peelen E, Tervaert JW, Hupperts R, Damoiseaux J.
    J Steroid Biochem Mol Biol; 2010 Jul 15; 121(1-2):243-6. PubMed ID: 20211254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.